Intercept prices IPO; Long-term safety study backs Pfizer pain drug; First tenant for Elk Run?;

Conversations on Twitter :

Should Lilly cut bait on solanezumab? Discussion on R&D strategies in tough AD area, and balance between targeting breakthroughs vs. incremental advances.
Is Sarepta positioned for success? A look at competitors in the DMD market raises doubts, but there may be room for multiple winners.

 @FierceBiotech: New special report: Top diabetes drug pipelines of 2012. Feature | Follow @FierceBiotech

 @JohnCFierce: Kythera IPO prices at high end of range (I don't write that very often). More | Follow @JohnCFierce

 @RyanMFierce: GSK will decide whether to grant access to the ID-less patient data based on scientific merit. Sounds subjective, but progress nonetheless. | Follow @RyanMFierce

> Intercept Pharmaceuticals says it has priced its 5 million IPO shares at $15, ahead of underwriting discounts. Release

> Pfizer ($PFE) says its pain drug ALO-02 demonstrated a long-term safety profile which was comparable to similar drugs. Story

> Tengion, a struggling regenerative medicine company in North Carolina, has completed a $15 million note offering with investors Celgene, RA Capital Management, Deerfield Management Company, Bay City Capital and HealthCap. Release

Pharma News

@FiercePharma: India's pharma industry is the country's 2nd-best at making billionaires. More | Follow @FiercePharma

> Minister: Jobs at Sanofi's Toulouse site mostly safe. Story

> Another compounding group shuts amid outbreak. Article

> Glaxo pledges to unveil all trial data, good, bad or ugly. Item

Medical Device News

 @FierceMedDev: As BSX has implied, the job cuts are coming. More | Follow @FierceMedDev

 @MarkHFierce: Not only is angel investing recovering, but much of it seems to be hitting medical device startups. More | Follow @MarkHFierce

 @DamianFierce: Four former Synthes execs have been effectively blacklisted from the life sciences industry. More | Follow @DamianFierce

> J&J's Cordis touts stent for femoral artery disease. Story

> Medical devices drive the start of an angel investor rebound. Item

> Quest Diagnostics slashing 400-600 jobs to save $65M. More

Pharma Manufacturing News

> Novasep investing in another API expansion. News

> Auctus Pharma API plant in India catches fire. Report

> Merck opens $21M Jakarta packaging plant. Story

Vaccines News

> GSK, Aeras partner for TB vaccine trial. More

> Merck taps Vaxxas for Nanopatch vaccine delivery. Story

> Pfizer's Prevnar 13 posts positive late-stage data. Report

> Takeda snaps up LigoCyte for $60M. Item